These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 358473)
1. The use of interferon in viral hepatitis B. Desmyter J Tex Rep Biol Med; 1977; 35():516-22. PubMed ID: 358473 [No Abstract] [Full Text] [Related]
2. [Hepatitis B and interferon]. Oda T; Suzuki H; Mitamura K Nihon Rinsho; 1978 May; Suppl():2166-7. PubMed ID: 691678 [No Abstract] [Full Text] [Related]
3. Usages of interferon and interferon inducers in man. Pollard RB Med Biol; 1980 Apr; 58(2):57-62. PubMed ID: 6159505 [No Abstract] [Full Text] [Related]
4. [Interferon therapy in chronic active viral hepatitis]. Lengyel G; Fehér J Orv Hetil; 1995 Jan; 136(1):3-7. PubMed ID: 7531317 [TBL] [Abstract][Full Text] [Related]
5. [Interferon and prospects for treatment of viral hepatitis with same]. Winogrodzka-Szaflik H Pol Tyg Lek; 1980 Mar; 35(10):365-7. PubMed ID: 6154289 [No Abstract] [Full Text] [Related]
6. Editor's interview: interferon. Young CW CA Cancer J Clin; 1972; 22(1):27-9. PubMed ID: 4622674 [No Abstract] [Full Text] [Related]
7. Anti-tumor effects of interferon and its possible use as an anti-neoplastic agent in man. Strander H Tex Rep Biol Med; 1977; 35():429-35. PubMed ID: 358466 [TBL] [Abstract][Full Text] [Related]
8. [Cytokines and hepatitis]. Degos F Rev Prat; 1993 Mar; 43(5):569-73. PubMed ID: 7688135 [TBL] [Abstract][Full Text] [Related]
9. [Interferon therapy of hepatitis B and C]. Jákó J Orv Hetil; 1995 Mar; 136(11):633. PubMed ID: 7535412 [No Abstract] [Full Text] [Related]
10. Developments in viral hepatitis. Zuckerman AJ J Med Virol; 1978; 3(1):1-8. PubMed ID: 215717 [TBL] [Abstract][Full Text] [Related]
11. [Interferon: its effects and clinical application]. Siegert R Internist (Berl); 1978 Dec; 19(12):659-63. PubMed ID: 370046 [No Abstract] [Full Text] [Related]
12. Interferons in the management of viral hepatitis. Zein NN Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of human interferon by body fluids. Cesario TC; Tilles JG Tex Rep Biol Med; 1977; 35():443-8. PubMed ID: 616673 [TBL] [Abstract][Full Text] [Related]
14. [Theory and practice of pharmacotherapy of chronic hepatitis B]. Juszczyk J Przegl Epidemiol; 1989; 43(2):183-91. PubMed ID: 2479056 [No Abstract] [Full Text] [Related]
15. The chimpanzee as a model to test the side effects of human interferons. Schellekens H; de Reus A; vd Meide PH J Med Primatol; 1984; 13(5):235-45. PubMed ID: 6210368 [TBL] [Abstract][Full Text] [Related]
16. Usages of interferon and interferon inducers in man: the first half of 1980. Pollard RB Med Biol; 1980 Dec; 58(6):293-9. PubMed ID: 6164882 [No Abstract] [Full Text] [Related]
18. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B. Zhang X; Zoulim F; Habersetzer F; Xiong S; Trépo C J Med Virol; 1996 Jan; 48(1):8-16. PubMed ID: 8825704 [TBL] [Abstract][Full Text] [Related]
19. [Antiviral preparations in the therapy of chronic viral hepatitis]. Geller LI Ter Arkh; 1990; 62(11):15-9. PubMed ID: 1710074 [TBL] [Abstract][Full Text] [Related]
20. Interferon and other therapies for hepatitis B and hepatitis C infections. Rothstein KD; Munoz SJ Clin Lab Med; 1996 Jun; 16(2):465-91. PubMed ID: 8792083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]